title: Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review.
abstract: We report a patient with a seronegative autoimmune panencephalitis, adding a subtype to the emerging spectrum of seronegative autoimmune encephalitis, and we review the sparse literature on isolated psychiatric presentations of autoimmune encephalitis. (A PubMed search for "seronegative autoimmune encephalitis," "nonvasculitic autoimmune inflammatory meningoencephalitis," and related terms revealed <25 cases.) A 15-year-old girl developed an acute-onset isolated psychosis with prominent negative symptoms and intermittent encephalopathy. Despite clinical worsening, her brain magnetic resonance imaging (MRI) scans remained normal for 7 years. Serology was negative for voltage-gated potassium channel (VGKC)-complex, N-methyl-D-aspartate receptor (NMDAR), and glutamic acid decarboxylase (GAD) autoantibodies. We excluded genetic, metabolic, paraneoplastic, degenerative, and infectious etiologies. The patient's symptoms remitted fully with immune therapy, but recurred in association with widespread bihemispheric brain lesions. Brain biopsy revealed mild nonvasculitic inflammation and prominent vascular hyalinization. Immune therapy with plasma exchanges cleared the MRI abnormalities but, 10 years after onset, the patient still suffers neuropsychiatric sequelae. We conclude that autoimmune panencephalitis seronegative for VGKC-complex, NMDAR, and GAD autoantibodies is a subtype of autoimmune encephalitis that can present with pure neuropsychiatric features and a normal brain MRI. Immunologic mechanisms may account for psychiatric symptoms in a subset of patients now diagnosed with classical psychotic disorders. Delay in starting immune therapy can lead to permanent neuropsychiatric sequelae. We propose a standardized classification system for the autoimmune encephalitides, integrating earlier pathology-oriented terms with more recently defined serologic and clinical phenotypes.
authors.affiliation: New York University Comprehensive Epilepsy Center, New York, NY 10016, USA. mna1024231@aol.com
authors.forename: Souhel
authors.initials: S
authors.lastname: Najjar
authors.forename: Daniel
authors.initials: D
authors.lastname: Pearlman
authors.forename: Orrin
authors.initials: O
authors.lastname: Devinsky
authors.forename: Amanda
authors.initials: A
authors.lastname: Najjar
authors.forename: Siddhartha
authors.initials: S
authors.lastname: Nadkarni
authors.forename: Tracy
authors.initials: T
authors.lastname: Butler
authors.forename: David
authors.initials: D
authors.lastname: Zagzag
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D001921:Brain / Q000473:pathology*; D001927:Brain Diseases / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D004660:Encephalitis; D005260:Female; D005968:Glutamate Decarboxylase / Q000276:immunology*; D050031:Hashimoto Disease / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D006801:Humans; D024642:Potassium Channels, Voltage-Gated / Q000276:immunology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*; D055815:Young Adult
chemical_list: D001323:Autoantibodies; D024642:Potassium Channels, Voltage-Gated; D016194:Receptors, N-Methyl-D-Aspartate; D005968:Glutamate Decarboxylase